Skip to main content
. 2022 Dec 28;14:51. doi: 10.1186/s13099-022-00523-y

Fig. 2.

Fig. 2

Prevalence of pks + and ETBF in the cohort. Controls – healthy participants; CRC – colorectal cancer patients. * P < 0.05, Fisher’s exact test